logo

For the Inventor, By the Inventor

New Providence, NJ, United States of America

Seemon H Pines

This inventor holds 12 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Helsinn Healthcare Sa, Ono Pharmaceutical Co., Ltd., Helsinn Therapeutics (u.s.), Inc.. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seemon H Pines. Retrieved from https://idiyas.com/inventor/seemon-h-pines-3a8muknn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • New Providence, NJ (US) (2010 - 2013)
  • Doylestown, PA (US) (2018)
  • Newton, PA (US) (2016 - 2021)

Company Filing History:

goldMedal8 out of 70 
 
Helsinn Healthcare Sa
 patents
silverMedal6 out of 575 
 
Ono Pharmaceutical Co., Ltd.
 patents
bronzeMedal2 out of 9 
 
Helsinn Therapeutics (u.s.), Inc.
 patents
4. 2 out of 186 
 
Ptc Therapeutics, Inc.
 patents
5. 1 out of 22 
 
Ono Pharmaceuticals Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 2010-2021

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 10905737 - Methods of producing anamorelin hydrochloride having controlled chloride content (2021-02-02),
2. 10576122 - Methods of producing anamorelin hydrochloride having controlled chloride content (2020-03-03),
3. 10300105 - Methods of producing anamorelin hydrochloride having controlled chloride content (2019-05-28),
4. 9981002 - Methods of producing anamorelin hydrochloride having controlled chloride content (2018-05-29),
5. 9975921 - Crystal forms of anamorelin (2018-05-22),
6. 9956261 - Methods of producing anamorelin hydrochloride having controlled chloride content (2018-05-01),
7. 9872883 - Methods of producing anamorelin hydrochloride having controlled chloride content (2018-01-23),
8. 9403867 - Methods of producing anamorelin hydrochloride having controlled chloride content (2016-08-02),
9. 8466173 - Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide (2013-06-18),
10. 8367841 - Processes for the preparation of 1,2,4-oxadiazole benzoic acids (2013-02-05),
11. 7825138 - Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide (2010-11-02),
12. 7678922 - Processes for the preparation of 1,2,4-oxadiazole benzoic acids (2010-03-16),

Title: Seemon H Pines: Innovator in Pharmaceutical Chemistry

Introduction

Seemon H Pines is a notable inventor based in New Providence, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work primarily focuses on the development of innovative methods and compositions that enhance the efficacy and safety of pharmaceutical products.

Latest Patents

Among his latest patents, Seemon H Pines has developed methods for producing anamorelin hydrochloride with controlled chloride content. This invention relates to particulate forms of anamorelin monohydrochloride, which are isolated in an amorphous and/or fine particulate state. The processes for making these particulate forms and the pharmaceutical compositions that incorporate them are designed to improve the therapeutic properties of the drug.

Career Highlights

Throughout his career, Seemon H Pines has worked with prominent companies in the pharmaceutical industry, including Helsinn Healthcare and Ono Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Seemon H Pines has collaborated with esteemed colleagues such as Shin-itsu Kuwabe and Takehiko Yanagimachi. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Seemon H Pines is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug formulation. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…